Literature DB >> 4333805

Specific antagonists for the myotropic action of angiotensin II and angiotensin I on the isolated rat colon.

D Gagnon, W K Park, D Regoli.   

Abstract

Substitutions of 8 phenylalanine with L-alanine and D-phenylalanine abolish the myotropic action of the angiotensin II (AT(II)) analogues and confer inhibitory properties on the molecule. [8-L-Ala]-AT(II) and [8-D-Phe]-AT(II) antagonize specifically the myotropic action of AT(II) and angiotensin I (AT(I)) on the rat colon, while the action of other myotropic agents (acetylcholine, 5 hydroxytryptamine) is not modified.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4333805      PMCID: PMC1665869     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  3 in total

1.  A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN.

Authors:  D REGOLI; J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

2.  Analogs of angiotensin II. II. Mechanism of receptor interaction.

Authors:  P A Khairallah; A Toth; F M Bumpus
Journal:  J Med Chem       Date:  1970-03       Impact factor: 7.446

3.  Stimulating action of catecholamines on isolated preparations of the rat colon and human and rabbit taeniae coli.

Authors:  S Belisle; D J Gagnon
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

  3 in total
  3 in total

1.  Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.

Authors:  N K Hollenberg; G H Williams; B Burger; I Ishikawa; D F Adams
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

2.  The rat isolated colon as a specific assay organ for angiotensin.

Authors:  D J Gagnon; P Sirois
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

3.  Changes in plasma levels of vasopressin and renin in response to haemorrhage in dogs.

Authors:  D Cousineau; D J Gagnon; P Sirois
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.